Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation

Diabetes Research and Clinical Practice

Volumn 88, Issue 3, 2010, Pages

  Kim, Jeong Su ^a   Lee, Han Cheol ^a   Choi, Bo Kyung ^a   Lee, Hye Won ^a   Park, Jin Sup ^a   Lee, Yong Hwan ^a   Ahn, Min Soo ^a   Hong, Taek Jong ^a   Kim, Sang Pil ^a   Lee, Sang Kwon ^a   Kim, Yeong Dae ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Coronary restenosis; Diabetes mellitus; Metabolic syndrome; Stents

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DEATH; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; RADIOGRAPHY; RESTENOSIS; RETROSPECTIVE STUDY; STENT; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78349242535     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.03.024     Document Type: Article

References (13)

1. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1988, 15:539-553.
2. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-6070.
3. DeFonzo R., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabet. Care 1991, 14:173-194.
4. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. North Am. 2004, 33:351-375.
5. Korean Institute of Health and Social Affairs The Third Korea National Health and Nutrition Examination Survey (KNHANES β) 2005, Korea Ministry of Health and Welfare, Seoul.
6. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabet. Care 2001, 24:683-689.
7. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
9. Steering Committee of the Western Pacific Region of the World Health Organization, the International Association for the Study of Obesity, the International Obesity Task Force The Asia-Pacific Perspective: Redefining Obesity and its Treatment 2000, Health Communications Australia Pty Limited, Melbourne, Australia, World Wide Web: http://www.diabetes.com.au/research/report_obesity.htm (accessed 11 April 2001).
10. Anuurad E., Shiwaku K., Nogi A., Kitajima K., Enkhmaa B., et al. The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J. Occup. Health 2003, 45:335-343.
11. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., et al. Impact of metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all cause in United State adults. Circulation 2004, 110:1245-1250.
12. Rana J.S., Monraats P.S., Jukema J.W., de Maat M.P., Kastelein J.J., et al. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Daibet. Care 2005, 28(4):873-877.
13. Hoffmann R., Stellbrink E., Radke P.W., Grawe A., Vogel G., et al. Impact of metabolic syndrome on angiographic and clinical events after coronary intervention using bare metal of sirolimus eluting stents. Am. J. Cardiol. 2007, 100(9):1347-1352.